1 domain / 2 areas / 1 specialization
Signant Health
Global eClinical and endpoint-science provider offering psychedelic-focused trial methodology, protocol-to-endpoint support, and purpose-built data quality workflows for psychiatry and CNS programs.
Clinical Trial Infrastructure Snapshot
Trial Technology & Data OperationsService Model
Technology Platform
Coverage
Global
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Verified
Apr 8, 2026
Lifecycle Coverage
Phase Coverage
Capabilities
Verification
Verified
Experience Notes
Signant publicly reports support for 35+ psychedelic trials and describes protocol design, specialized rater training, and endpoint data workflows tailored for psychedelic studies.
Service Notes
Focus on endpoint reliability and rater quality in psychedelic and CNS studies, with integrated digital tools spanning study design through evidence generation.
Quick Facts
- Website
- Visit